181
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Atypical teratoid/rhabdoid tumor in adult: case series and an integrated survival analysis

, , , , , & show all
Pages 425-432 | Received 22 Sep 2019, Accepted 01 Feb 2021, Published online: 17 Feb 2021
 

Abstract

Background

Atypical teratoid/rhabdoid tumor (AT/RT) is well documented in children but less so in adults because of its rarity.

Method

We report a series of five cases, a literature review and quantitative analysis of the survival outcome of adult AT/RT patients.

Results

Seventy-four patients including our five cases (male: female = 16: 58) were evaluated, whose median age was 32.5 years (18–80 years). The commonest location was the sellar region. Median overall survival (OS) was 12.5 months (0.5–204.00 months). Chemotherapy was associated with OS (HR: 0.349, 95%CI: 0.176–0.694, p = 0.003), while other factors did not influence OS. From Kaplan-Meier analysis, surgery combining postoperative chemotherapy and radiotherapy was associated with better prognosis (Log Rank: χ2 = 14.662, p = 0.001).

Conclusions

Adult AT/RT is commoner in females and tends to recur rapidly after surgical resection. Chemotherapy may provide a survival benefit. Surgery combined with postoperative chemotherapy and radiotherapy was associated with better prognosis for adult AT/RT patients, though the overall prognosis was still poor.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.